new antibiotics established under the Generating New Antibiotic Incentives Now (GAIN) Act. In 2019, FDA granted "Fast Track" designation to ibezapolstat for the treatment of patients with CDI. The CDC ...
Scalded skin syndrome from staph bacteria generally covers the entire body. Infants are particularly susceptible. Learn which ...
New York-based Ascent Consumer Products Inc. is voluntarily recalling its SinuCleanse Nasal Wash System, which is sold ...
New York-based Ascent Consumer Products Inc. is voluntarily recalling its SinuCleanse Nasal Wash System, which is sold ...
Superbugs, which are antibiotic-resistant infections, are on the rise globally. Experts say the UK isn't doing enough to ...
Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...
British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...
difficile Infection ... Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant Staphylococcus aureus ...
A newborn baby who died in a Glasgow hospital after developing an infection was “stable” the day before she passed away, an ...
Singaporean medic Dr Samuel Choudhury shared the cautionary story of Jo Gilchrist, an Australian woman who became paralysed ...
Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc. and SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" or "SciClone") today announced the NMPA (National Medical ...
A new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus aureus infections, highlighting a major public health concern.
Sommige resultaten zijn verborgen omdat ze mogelijk niet toegankelijk zijn voor u.
Niet-toegankelijke resultaten weergeven